Thursday, August 11, 2005

Guardian® RT Continuous Glucose Monitoring System

Filed under: Medicine

Medtronic is announcing that the FDA has approved its real-time Guardian® RT Continuous Glucose Monitoring System. Medtronic believes that its monitor will provide better diabetic monitoring and management.

This is how the system works:

The Guardian RT system is not implanted. A tiny sensor inserts easily under your skin in a virtually painless process. Once the sensor is in, the system records glucose levels every five minutes and sends them automatically to a discrete monitor that you wear like a pager. The sensor measures glucose in the interstitial fluid found between your body's cells. You typically discard and replace the sensor after three days of use. Alarms can be set to alert you to potentially dangerous highs and lows. Trend reports and charts can be viewed once data is downloaded to a personal computer using Solutions™ Software for Guardian. You are still required to take fingersticks prior to adjusting therapy and in order to calibrate the glucose sensor...

The Guardian RT system is indicated for use by Type 1 and Type 2 diabetes patients, 18 years and older, who desire better glucose control to improve their health and quality of life.

More at Medtronic...

                (2)